Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease.

BACKGROUND Cellular antioxidant enzymes such as glutathione peroxidase 1 and superoxide dismutase have a central role in the control of reactive oxygen species. In vitro data and studies in animal models suggest that these enzymes may protect against atherosclerosis, but little is known about their relevance to human disease. METHODS We conducted a prospective study among 636 patients with suspected coronary artery disease, with a median follow-up period of 4.7 years (maximum, 5.4) to assess the risk of cardiovascular events associated with base-line erythrocyte glutathione peroxidase 1 and superoxide dismutase activity. RESULTS Glutathione peroxidase 1 activity was among the strongest univariate predictors of the risk of cardiovascular events, whereas superoxide dismutase activity had no association with risk. The risk of cardiovascular events was inversely associated with increasing quartiles of glutathione peroxidase 1 activity (P for trend <0.001); patients in the highest quartile of glutathione peroxidase 1 activity had a hazard ratio of 0.29 (95 percent confidence interval, 0.15 to 0.58; P<0.001), as compared with those in the lowest quartile. Glutathione peroxidase 1 activity was affected by sex and smoking status but retained its predictive power in these subgroups. After adjustment for these and other cardiovascular risk factors, the inverse association between glutathione peroxidase 1 activity and cardiovascular events remained nearly unchanged. CONCLUSIONS In patients with coronary artery disease, a low level of activity of red-cell glutathione peroxidase 1 is independently associated with an increased risk of cardiovascular events. Glutathione peroxidase 1 activity may have prognostic value in addition to that of traditional risk factors. Furthermore, increasing glutathione peroxidase 1 activity might lower the risk of cardiovascular events.

[1]  M. Shingu,et al.  Human vascular smooth muscle cells and endothelial cells lack catalase activity and are susceptible to hydrogen peroxide , 1985, Inflammation.

[2]  Eman M. Alissa,et al.  The controversy surrounding selenium and cardiovascular disease: a review of the evidence. , 2003, Medical science monitor : international medical journal of experimental and clinical research.

[3]  T. Cohnert,et al.  Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[4]  L. Oberley,et al.  Deficiency of Glutathione Peroxidase-1 Sensitizes Hyperhomocysteinemic Mice to Endothelial Dysfunction , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[5]  G. Buonocore,et al.  Gender‐related differences in erythrocyte glutathione peroxidase activity in healthy subjects , 2002, Clinical endocrinology.

[6]  J. Loscalzo,et al.  Heterozygous Cellular Glutathione Peroxidase Deficiency in the Mouse: Abnormalities in Vascular and Cardiac Function and Structure , 2002, Circulation.

[7]  D. Harrison,et al.  Extracellular superoxide dismutase and cardiovascular disease. , 2002, Cardiovascular research.

[8]  A. Lusis,et al.  Identification of 5-Lipoxygenase as a Major Gene Contributing to Atherosclerosis Susceptibility in Mice , 2002, Circulation research.

[9]  F. Cambien,et al.  Interleukin-18 Is a Strong Predictor of Cardiovascular Death in Stable and Unstable Angina , 2002, Circulation.

[10]  D. Steinberg,et al.  Is the Oxidative Modification Hypothesis Relevant to Human Atherosclerosis?: Do the Antioxidant Trials Conducted to Date Refute the Hypothesis? , 2002, Circulation.

[11]  J. Loscalzo,et al.  Cellular glutathione peroxidase deficiency and endothelial dysfunction. , 2002, American journal of physiology. Heart and circulatory physiology.

[12]  S. Blankenberg,et al.  Circulating Cell Adhesion Molecules and Death in Patients With Coronary Artery Disease , 2001, Circulation.

[13]  S. Blankenberg,et al.  Impact of Viral and Bacterial Infectious Burden on Long-Term Prognosis in Patients With Coronary Artery Disease , 2001, Circulation.

[14]  C. Epstein,et al.  Changes in Expression of Antioxidant Enzymes Affect Cell-Mediated LDL Oxidation and Oxidized LDL-Induced Apoptosis in Mouse Aortic Cells , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[15]  U. de Faire,et al.  Oxidative stress, human genetic variation, and disease. , 2001, Archives of biochemistry and biophysics.

[16]  Christopher K. Glass,et al.  Atherosclerosis The Road Ahead , 2001, Cell.

[17]  J. Arthur.  The glutathione peroxidases , 2001, Cellular and Molecular Life Sciences CMLS.

[18]  U. de Faire,et al.  Phenotype determination of a common Pro-Leu polymorphism in human glutathione peroxidase 1. , 2000, Blood cells, molecules & diseases.

[19]  Y. Liu,et al.  Effect of selenium on human myocardial glutathione peroxidase gene expression. , 2000, Chinese medical journal.

[20]  O. Werz,et al.  Glutathione peroxidase-1 but not -4 is involved in the regulation of cellular 5-lipoxygenase activity in monocytic cells. , 2000, The Biochemical journal.

[21]  M. Rayman,et al.  The importance of selenium to human health , 2000, The Lancet.

[22]  R. Ross.  Atherosclerosis is an inflammatory disease , 1999 .

[23]  H. Sies,et al.  Glutathione and its role in cellular functions. , 1999, Free radical biology & medicine.

[24]  J. Strain,et al.  Antioxidant enzymes, inflammatory indices and lifestyle factors in older men: a cohort analysis. , 1999, QJM : monthly journal of the Association of Physicians.

[25]  Yunchao Su,et al.  Effect of cigarette smoke extract on nitric oxide synthase in pulmonary artery endothelial cells. , 1998, American journal of respiratory cell and molecular biology.

[26]  C. di Ilio,et al.  Glutathione-related antioxidant defenses in human atherosclerotic plaques. , 1998, Circulation.

[27]  J. Nielsen,et al.  Antioxidative enzyme activities in human erythrocytes. , 1997, Clinical chemistry.

[28]  G. Refael,et al.  Dietary selenium increases cellular glutathione peroxidase activity and reduces the enhanced susceptibility to lipid peroxidation of plasma and low-density lipoprotein in kidney transplant recipients. , 1997, Transplantation.

[29]  F. Kok,et al.  Association between toenail selenium and risk of acute myocardial infarction in European men. The EURAMIC Study. European Antioxidant Myocardial Infarction and Breast Cancer. , 1997, American journal of epidemiology.

[30]  W. Willett,et al.  Plasma levels of the antioxidant selenium and risk of myocardial infarction among U.S. physicians. , 1995, The American journal of cardiology.

[31]  D. Schomburg,et al.  Diversity of glutathione peroxidases. , 1995, Methods in enzymology.

[32]  H. Hein,et al.  Serum selenium concentration and risk of ischaemic heart disease in a prospective cohort study of 3000 males. , 1992, Atherosclerosis.

[33]  R. Rauramaa,et al.  Relationship of serum selenium and antioxidants to plasma lipoproteins, platelet aggregability and prevalent ischaemic heart disease in Eastern Finnish men. , 1988, Atherosclerosis.

[34]  L. Flohe.  Glutathione peroxidase. , 1988, Basic life sciences.

[35]  J. Remacle,et al.  Comparative study of the enzymatic defense systems against oxygen-derived free radicals: the key role of glutathione peroxidase. , 1987, Free radical biology & medicine.

[36]  W. Prellwitz,et al.  A methodological comparison of hydride and carbon furnace atomic absorption spectroscopy for the determination of selenium in serum. , 1982, Clinica chimica acta; international journal of clinical chemistry.

[37]  W. Valentine,et al.  Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. , 1967, The Journal of laboratory and clinical medicine.